发明名称 Compounds for treating diseases wherein inhibition of Fas-mediated apoptosis is indicated
摘要 The compounds of Formula (I) may be used in the manufacture of medicaments for inhibiting the expression of Fas, for treating autoimmune diseases and for inhibiting tumor growth and metastasis. In formula (I); R7-R13 are independently H or OH; and A is a moiety of Formula (II), wherein; R1 is hydrogen, lower alkanoyl of up to 6 carbon atoms or aroyl selected from benzoyl and naphthoy!; R2 is hydrogen, lower alkyl of up to 6 carbon atoms or arylalkyl selected from benzyl, phenylethyl and phenylpropyl; R3 is hydrogen or lower alkyl of up to 6 carbon atoms; R4 is hydrogen or lower alkyl of up to 6 carbon atoms, or when X is oxygen, R4 together with R5 can represent CH2O; X is a single bond, CH2, oxygen or sulfur; Ar is selected from phenyl, naphthyl, indanyl and tetrahydronaphthyl; R5 and R6 are individually selected from hydrogen, fluorine, chlorine, bromine, hydroxyl, lower alkyl of up to 6 carbon atoms, a CONH2 group, lower alkoxy of up to 6 carbon atoms, benzyloxy, lower alkylthio of up to 6 carbon atoms, lower alkysulphinyl of up to 6 carbon atoms and lower alkylsulphonyl of up to 6 carbon atoms; or R5 and R6 together represent methylenedioxy. A preferred compound of the formula above is carvedilol (1-(carbazol-4-yloxy-3-[(2-(o-methoxyphenoxy)ethyl]amino]-2-propanol).
申请公布号 NZ334307(A) 申请公布日期 2000.11.24
申请号 NZ19970334307 申请日期 1997.08.22
申请人 BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION - SMITHKLINE BECKMAN CORPORATION LIMITED PARTNERSHIP NO 1 发明人 FEUERSTEIN, GIORA ZEEV;YUE, TIAN-LI
分类号 A61K45/00;A61K31/40;A61K31/403;A61P9/00;A61P35/00;A61P37/00;A61P43/00;C07D209/88;(IPC1-7):A61K31/40 主分类号 A61K45/00
代理机构 代理人
主权项
地址